FrancophonIA/ELRC3.0 huggingface dataset:
English: Figure 1: Kaplan-Meier Plot of Radiographic Progression-free Survival; Intent-to-treat Population (Study PCR3011)
Danish: Figur 1: Kaplan-Meier-afbildning af radiografisk progressionsfri overlevelse; intent-to-treatpopulation (studie PCR3011)
English: Day
Danish: Dag
English: - This medicine also contains approximately 27 mg of sodium in a two tablet daily dose.
Danish: - Dette lægemiddel indeholder også ca. 27 mg natrium i den daglige dosis på to tabletter.
English: Tell your doctor if you are receiving medicine - used to treat heart rhythm problems (e.g. quinidine, procainamide, amiodarone and sotalol); - known to increase the risk of heart rhythm problems [e.g. methadone (used for pain relief and part of drug addiction detoxification), moxifloxacin (an antibiotic), antipsychotics (used for serious mental illnesses)].
Danish: - vides at øge risikoen for problemer med hjerterytmen [f.eks. methadon (som anvendes til smertelindring samt i forbindelse med afvænning ved stofmisbrug), moxifloxacin (et antibiotikum), antipsykotika (som anvendes til alvorlige psykiske lidelser)].
English: Gastrointestinal disorders very common: diarrhoea common: dyspepsia
Danish: Mave-tarm-kanalen meget almindelige: diaré almindelige: dyspepsi
English: = confidence interval; ECOG = Eastern Cooperative Oncology Group performance score; HR = hazard ratio; NE = not evaluable
Danish: ECOG=Eastern Cooperative Oncology Groupfunktionsscore.
English: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Danish: Dette lægemiddel indeholder lactose og bør ikke anvendes til patienter med arvelig galactoseintolerans, en særlig form af hereditær lactasemangel (Lapp lactase deficiency) eller glucose/galactosemalabsorption.
English: In Phase 3 clinical studies, treatment discontinuations due to ALT and AST increases or abnormal hepatic function were reported in 1.1% of patients treated with abiraterone acetate and 0.6% of patients treated with placebo; no deaths were reported due to hepatotoxicity events.
Danish: I de fase 3 kliniske studier blev seponering på grund af ALAT- og ASATstigning eller unormal leverfunktion rapporteret hos 1,1 % af de patienter, der fik abirateronacetat, og hos 0,6 % af de patienter, der fik placebo.
English: A statistically significant improvement in OS in favor of AA-P plus ADT was observed with a 38% reduction in the risk of death compared to Placebo plus ADT (HR=0.621; 95% CI: 0.509, 0.756; p<0.0001), crossing the pre-specified boundary for OS at Interim Analysis 1 of 0.010 (see Table 3 and Figure 2).
Danish: Der observeredes en statistisk signifikant forbedring i OS til fordel for AA-P plus ADT med en 38 % reduktion i risiko for død sammenlignet med placebo plus ADT (HR=0,621; 95 % KI: 0,509: 0,756; p < 0,0001), hvilket er på den anden side af den på forhånd specificerede stopgrænse for OS på 0,010 ved interimanalyse 1 (se tabel 3 og figur 2).
English: Use with ZYTIGA is not recommended (see section 5.1).
Danish: Anvendelse sammen med ZYTIGA frarådes (se pkt.
English: Overall Survival (months) Median (95% CI)
Danish: Samlet overlevelse (måneder) Median (95 % KI)
English: Pain
Danish: Smerter
English: Breast-feeding ZYTIGA is not for use in women.
Danish: Amning ZYTIGA er ikke beregnet til kvinder.
English: Microcrystalline cellulose (silicified) Croscarmellose sodium Hypromellose 2910 (15 mPa.S) Lactose monohydrate Magnesium stearate Colloidal anhydrous silica Sodium laurilsulfate
Danish: Mikrokrystallinsk cellulose (silicificeret) Croscarmellosenatrium Hypromellose 2910 (15 mPa.S) Lactosemonohydrat
English: The majority of circulating radioactivity (approximately 92%) is found in the form of metabolites of abiraterone.
Danish: Abiraterons metabolitter tegner sig for hovedparten af radioaktiviteten i blodet (ca. 92 %).
English: Time to deterioration in ECOG performance score by ≥ 1 point: The median time to deterioration in ECOG performance score by ≥ 1 point was 12.3 months for patients receiving ZYTIGA and 10.9 months for patients receiving placebo (HR = 0.821; 95% CI: [0.714; 0.943], p = 0.0053).
Danish: Tiden indtil forringelse af ECOG-performancescore med ≥ 1 point: Mediantiden indtil forringelse af ECOG-performancescore med ≥ 1 point var 12,3 måneder for patienter, der fik ZYTIGA, og 10,9 måneder for patienter, der fik placebo (HR=0,821); 95 % KI: [0,714; 0,943], p=0,0053).
English: Marked increases in liver enzymes leading to treatment discontinuation or dose modification occurred in controlled clinical studies (see section 4.8).
Danish: I kontrollerede kliniske studier sås markante stigninger i leverenzymer, hvilket førte til seponering af behandlingen eller dosismodifikation (se pkt.
English: Radiographic Progression-Free Survival - Stratified Analysis; Intent-to-treat Population (Study PCR3011)
Danish: Tabel 2: Radiografisk progressionsfri overlevelse - stratificeret analyse; intent-to-treatpopulation (studie PCR3011)
English: The median radiographic progression-free survival was 5.6 months for patients treated with ZYTIGA and 3.6 months for patients who received placebo (HR = 0.673; 95% CI: [0.585; 0.776], p < 0.0001).
Danish: Median radiografisk progressionsfri overlevelse var 5,6 måneder for patienter, der blev behandlet med ZYTIGA, og 3,6 måneder for patienter, der fik placebo (HR=0,673; 95 % KI: [0,585; 0,776]; p < 0,0001).
English: BOTTLE LABEL 250 mg
Danish: BEHOLDERENS ETIKET 250 mg
English: Time to PSA progression based on PCWG2 criteria: The median time to PSA progression was 33.2 months for patients receiving ZYTIGA and 7.4 months for patients receiving placebo (HR = 0.299; 95% CI: [0.255, 0.352], p <0.0001).
Danish: Tid til PSA-progression baseret på PCWG2-kriterier: Mediantiden til PSA-progression var 33,2 måneder for patienter, der fik ZYTIGA, og 7,4 måneder for patienter, der fik placebo (HR = 0,299; 95 % KI: [0,255, 0,352], p < 0,0001).
English: CARTON 500 mg
Danish: KARTON 500 mg
English: To be taken into consideration by patients on a controlled sodium diet.
Danish: Patienter på natrium- eller saltfattig diæt skal tage hensyn hertil.
English: In studies 3011 and 302, patients with atrial fibrillation, or other cardiac arrhythmia requiring medical therapy were excluded.
Danish: Patienter med atrieflimren eller anden hjertearytmi, der kræver medicinsk behandling, blev ekskluderet fra studie 3011 og 302.
English: No dose adjustment is necessary for patients with renal impairment (see section 5.2).
Danish: Det er ikke nødvendigt at justere dosis hos patienter med nedsat nyrefunktion (se pkt.
English: Time to opiate use for cancer pain: The median time to opiate use for prostate cancer pain at the time of final analysis was 33.4 months for patients receiving ZYTIGA and was 23.4 months for patients receiving placebo (HR = 0.721; 95% CI: [0.614; 0.846], p < 0.0001).
Danish: Tiden indtil anvendelse af opiat mod cancersmerter: Mediantiden indtil brug af opiat mod prostatacancersmerter på tidspunktet for den endelige analyse var 33,4 måneder for patienter, der fik ZYTIGA, og 23,4 måneder for patienter, der fik placebo (HR =0,721; 95 % KI [0,614; 0,846], p < 0,0001).
English: - If you are having sex with a pregnant woman, use a condom to protect the unborn child.
Danish: - Brug kondom for at beskytte fostret, hvis du har sex med en gravid kvinde.
English: (mHSPC) in adult men in combination with androgen deprivation therapy (ADT) (see section
Danish: • Behandling af nydiagnosticeret, metastaserende hormonfølsom prostatacancer (mHSPC) med høj risiko hos voksne mænd i kombination med androgen deprivationsbehandling (ADT) (se pkt.
English: Musculoskeletal and connective tissue disorders uncommon: myopathy, rhabdomyolysis
Danish: Knogler, led, muskler og bindevæv ikke almindelige: myopati, rabdomyolyse
English: - The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone (K29/K32), colloidal anhydrous silica, and sodium laurilsulfate (see section 2, “ZYTIGA contains lactose and sodium”).
Danish: - Øvrige indholdsstoffer: mikrokrystallinsk cellulose (silicificeret), croscarmellosenatrium, hypromellose 2910 (15 mPa.S), lactosemonohydrat, magnesiumstearat, kolloid vandfri silica, natriumlaurilsulfat; (se ”ZYTIGA indeholder lactose og natrium” under punkt 2).
English: Time to subsequent therapy: The median time to subsequent therapy at the time of interim analysis was not reached for patients receiving ZYTIGA and was 21.6 months for patients receiving placebo (HR = 0.415; 95% CI: [0.346, 0.497], p <0.0001).
Danish: Tid til efterfølgende behandling: På tidspunktet for interimanalysen var mediantiden til efterfølgende behandling ikke nået hos patienter, der fik ZYTIGA, og den var 21,6 måneder for patienter, der fik placebo (HR = 0,415; 95 % KI: [0,346, 0,497], p < 0,0001).
English: In the active arm, ZYTIGA was administered at a dose of 1000 mg daily in combination with low dose prednisone 5 mg once daily in addition to ADT
Danish: I den aktive arm blev ZYTIGA administreret i en dosis på 1000 mg dagligt i kombination med lavdosis prednison 5 mg en gang dagligt udover ADT (LHRH-agonist eller orkiektomi), som var standardbehandlingen.
English: Eleven percent of patients enrolled had an ECOG performance score of 2; 70% had radiographic evidence of disease progression with or without PSA progression; 70% had received one prior cytotoxic chemotherapy and 30% received two.
Danish: 70 % havde radiografisk dokumenteret sygdomsprogression med eller uden PSA-progression.
English: * p-value is derived from a log-rank test stratified by baseline ECOG score (0 or 1) ** Hazard ratio < 1 favours ZYTIGA
Danish: * p-værdi er beregnet fra en log-rank test stratificeret ved baseline-ECOG-score (0 eller 1) ** Hazard ratio < 1 indikere en fordel for ZYTIGA
English: Time to pain progression: The median time to pain progression was not reached for patients receiving ZYTIGA and was 16.6 months for patients receiving placebo (HR = 0.695; 95% CI: [0.583, 0.829], p <0.0001).
Danish: Tid til smerteprogression: Mediantiden til smerteprogression blev ikke nået for patienter, der fik ZYTIGA, og var 16,6 måneder for patienter, der fik placebo (HR = 0,695; 95 % KI: [0,583, 0,829], p < 0,0001).
English: The median time to PSA progression was 10.2 months for patients treated with ZYTIGA and 6.6 months for patients treated with placebo (HR = 0.580; 95% CI: [0.462; 0.728], p < 0.0001).
Danish: Median tid til PSA-progression var 10,2 måneder for patienter, der blev behandlet med ZYTIGA, og 6,6 måneder for patienter, der fik placebo (HR=0,580; 95 % KI: [0,462; 0,728]; p < 0,0001).
English: Common (may affect up to 1 in 10 people):
Danish: Almindelige (kan berøre op til 1 ud af 10 behandlede):
English: Time to initiation of chemotherapy: The median time to initiation of chemotherapy was not reached for patients receiving ZYTIGA and was 38.9 months for patients receiving placebo (HR = 0.443; 95% CI: [0.349, 0.561], p < 0.0001).
Danish: Tid til påbegyndelse af kemoterapi: Mediantiden til påbegyndelse af kemoterapi blev ikke nået for patienter, der fik ZYTIGA, og var 38,9 måneder for patienter, der fik placebo (HR = 0,443; 95 % KI: [0,349, 0,561], p < 0,0001).
English: Time to PSA progression based on PCWG2 criteria: The median time to PSA progression was 11.1 months for patients receiving ZYTIGA and 5.6 months for patients receiving placebo (HR = 0.488; 95% CI: [0.420; 0.568], p < 0.0001).
Danish: Tid til PSA-progression baseret på PCWG-kriterier: Mediantiden til PSA-progression var 11,1 måneder for patienter, der fik ZYTIGA, og 5,6 måneder for patienter, der fik placebo (HR=0,488; 95 % KI: [0,420; 0,568], p < 0,0001).
English: Time to initiation of cytotoxic chemotherapy: The median time to initiation of cytotoxic chemotherapy was 25.2 months for patients receiving ZYTIGA and 16.8 months for patients receiving placebo (HR = 0.580; 95% CI: [0.487; 0.691], p < 0.0001).
Danish: Tiden indtil påbegyndelse af cytotoksisk kemoterapi: Mediantiden indtil påbegyndelse af cytotoksisk kemoterapi var 25,2 måneder for patienter, der fik ZYTIGA, og 16,8 måneder for patienter, der fik placebo (HR=0,580; 95 % KI: [0,487; 0,69], p < 0,0001).
English: NE = Not estimated * p-value is derived from a log-rank test stratified by baseline ECOG score (0 or 1) ** Hazard ratio < 1 favours ZYTIGA
Danish: NE= Ikke estimeret * p-værdi er beregnet fra en log-rank test stratificeret ved baseline-ECOG-score (0 eller 1) ** Hazard ratio < 1 indikere en fordel for ZYTIGA
English: - Severe hepatic impairment [Child-Pugh Class C (see sections 4.2, 4.4 and 5.2)].
Danish: - Svært nedsat leverfunktion [Child--Pugh-klasse C (se pkt.
English: abiraterone acetate should not be used in patients with severe hepatic impairment (see sections 4.2, 4.3 and 4.4).
Danish: Abirateronacetat bør ikke anvendes til patienter med svært nedsat leverfunktion (se pkt.
English: What ZYTIGA is and what it is used for What you need to know before you take ZYTIGA How to take ZYTIGA
Danish: Det skal du vide, før du begynder at tage ZYTIGA Sådan skal du tage ZYTIGA Bivirkninger
English: Uncommon (may affect up to 1 in 100 people):
Danish: Ikke almindelige (kan berøre op til 1 ud af 100 patienter):
English: Overall Survival, Stratified Analysis; Intent-to-treat Population (Study PCR3011) AA-P
Danish: Tabel 3: Samlet overlevelse, stratificeret analyse; intent-to-treat-population (studie PCR3011)
English: Skeletal-related events
Danish: Knoglerelaterede hændelser
English: Table 4: Study 302: Radiographic progression-free survival of patients treated with either ZYTIGA or placebo in combination with prednisone or prednisolone plus LHRH analogues or prior orchiectomy ZYTIGA (N = 546)
Danish: Tabel 4: Studie 302: Radiografisk progressionsfri overlevelse hos patienter behandlet med enten ZYTIGA eller placebo i kombination med prednison eller prednisolon plus LHRH-analog eller tidligere orkiektomi ZYTIGA (N=546)
English: Each tablet contains 250 mg of abiraterone acetate.
Danish: Hver tablet indeholder 250 mg abirateronacetat.
English: b 0.466 (0.394, 0.550) Note: += censored observation, NE=not estimable.
Danish: Note: += Censureret observation, NE= ikke evaluerbar.
English: In fertility studies in both male and female rats, abiraterone acetate reduced fertility, which was completely reversible in 4 to 16 weeks after abiraterone acetate was stopped.
Danish: I fertilitetsstudier med både han- og hunrotter reducerede abirateronacetat fertiliteten.
English: Swallow the tablets whole with water.
Danish: Tabletterne skal sluges hele med vand.
English: ZYTIGA should not be used in patients with severe hepatic impairment (see sections 4.3, 4.4 and 5.2).
Danish: ZYTIGA bør ikke anvendes til patienter med svært nedsat leverfunktion (se pkt.
English: Each film-coated tablet contains 500 mg of abiraterone acetate.
Danish: Hver filmovertrukken tablet indeholder 500 mg abirateronacetat.
English: Figure 4: Kaplan Meier curves of radiographic progression-free survival in patients treated with either ZYTIGA or placebo in combination with prednisone or prednisolone plus LHRH analogues or prior orchiectomy (At second interim analysis of OS-Investigator Review)
Danish: Figur 4: Kaplan Meier-kurver af radiografiske progressionsfri overlevelse hos patienter behandlet med enten ZYTIGA eller placebo i kombination med prednison eller prednisolon plus LHRH-analog eller tidligere orkiektomi (ved den anden interimanalyse af OS-investigators vurdering)
English: Figure 5: Kaplan Meier survival curves of patients treated with either ZYTIGA or placebo in combination with prednisone or prednisolone plus LHRH analogues or prior orchiectomy, final analysis
Danish: Figur 5: Kaplan Meier overlevelseskurver for patienter behandlet med enten ZYTIGA eller placebo i kombination med prednison eller prednisolon plus LHRH-analog eller tidligere orkiektomi, endelig analyse
English: Table 5: Study 302: Radiographic progression-free survival of patients treated with either ZYTIGA or placebo in combination with prednisone or prednisolone plus LHRH analogues or prior orchiectomy (At second interim analysis of OS-Investigator Review)
Danish: Tabel 5: Studie 302: Radiografisk progressionsfri overlevelse hos patienter behandlet med enten ZYTIGA eller placebo i kombination med prednison eller prednisolon plus LHRH-analog eller tidligere orkiektomi (ved den anden interimanalyse af OSinvestigators vurdering)
English: Final survival analysis Deaths Median overall survival in months (95% CI) p-value* Hazard ratio** (95% CI)
Danish: p-værdi* Hazard ratio** (95 % KI) Endelig overlevelsesanalyse Dødsfald (%) Median samlet overlevelse (i måneder) (95 % KI) p-værdi* Hazard ratio** (95 % KI)
English: Figure 3: Kaplan Meier curves of radiographic progression-free survival in patients treated with either ZYTIGA or placebo in combination with prednisone or prednisolone plus LHRH analogues or prior orchiectomy
Danish: Figur 3: Kaplan Meier kurver af radiografisk progressionsfri overlevelse hos patienter, der er behandlet med enten ZYTIGA eller placebo i kombination med prednison eller prednisolon plus LHRH-analoger eller tidligere orkiektomi
English: Table 7: Overall survival of patients treated with either ZYTIGA or placebo in combination with prednisone or prednisolone plus LHRH analogues or prior orchiectomy
Danish: Tabel 7: Samlet overlevelse hos patienter i behandling med enten ZYTIGA eller placebo i kombination med prednison eller prednisolon plus LHRH-analog- eller tidligere orkiektomi
English: Table 6: Study 302: Overall survival of patients treated with either ZYTIGA or placebo in combination with prednisone or prednisolone plus LHRH analogues or prior orchiectomy
Danish: Tabel 6: Studie 302: Samlet overlevelse hos patienter behandlet med enten ZYTIGA eller placebo i kombination med prednison eller prednisolon plus LHRH-analog eller tidligere orkiektomi.
English: - If you forget to take ZYTIGA or prednisone or prednisolone for more than one day, talk to your doctor without delay.
Danish: - Kontakt straks lægen, hvis du har glemt at tage ZYTIGA, prednison eller prednisolon i mere end en dag.
English: It should be taken at least two hours after eating and no food should be eaten for at least one hour after taking ZYTIGA.
Danish: ZYTIGA må derfor ikke indtages i forbindelse med et måltid, men indtages mindst to timer efter fødeindtagelse, og føde må ikke indtages i mindst én time efter indtagelse af ZYTIGA.
English: Each film-coated tablet contains 500 mg abiraterone acetate.
Danish: En filmovertrukken tablet indeholder 500 mg abirateronacetat.
English: versus 4.7 months in the placebo group.
Danish: Tiden til smerteprogression ved den 25. percentil var 7,4 måneder i ZYTIGA-gruppen versus 4,7 måneder i placebo-gruppen.
English: - Keep this medicine out of the sight and reach of children.
Danish: - Opbevar lægemidlet utilgængeligt for børn.
English: Figure 6: Kaplan Meier survival curves of patients treated with either ZYTIGA or placebo in combination with prednisone or prednisolone plus LHRH analogues or prior orchiectomy
Danish: Figur 6: Kaplan Meier-overlevelseskurver for patienter, der fik enten ZYTIGA eller placebo i kombination med prednison eller prednisolon plus LHRH-analog eller tidligere orkiektomi
English: Renal and urinary disorders common: haematuria
Danish: Nyrer og urinveje almindelige: hæmaturi
English: Tablet core
Danish: Magnesiumstearat
English: Range p value Hazard ratio (95% CI) Note:+= censored observation, NE = not estimable.
Danish: HR=hazard ratio; NE=ikke evaluerbar.
English: Based on its mechanism of action, this medicinal product may harm a developing foetus; therefore, women who are pregnant or may be pregnant should not handle it without protection, e.g., gloves.
Danish: Gravide kvinder eller kvinder, som kan være gravide, bør ikke håndtere det uden at anvende sikkerhedsudstyr, f.eks. handsker.
English: Following oral administration of
Danish: Efter oral administration af 1.000 mg
English: Patients with elevations of ALT or
Danish: Forsøgspersoner med risiko
English: Assess cardiac function as clinically indicated, institute appropriate management and consider discontinuation of this treatment if there is a clinically significant decrease in cardiac function (see section 4.2).
Danish: I tilfælde af et klinisk signifikant fald i hjertefunktionen bør det overvejes at seponere ZYTIGA (se pkt.
English: Hypertension, hypokalaemia, fluid retention and cardiac failure due to mineralocorticoid excess ZYTIGA may cause hypertension, hypokalaemia and fluid retention (see section 4.8) as a consequence of increased mineralocorticoid levels resulting from CYP17 inhibition (see section 5.1).
Danish: 4.8) som følge af de forhøjede mineralokortikoidniveauer forårsaget af CYP17-hæmning (se pkt.
English: No dose adjustment is necessary for patients with pre-existing mild hepatic impairment.
Danish: Hos patienter med let nedsat leverfunktion er dosisjustering ikke nødvendig.
English: Questions and answers
Danish: Frågor och svar
English: Page 2/2
Danish: Sida 2/2
English: What did the company present to support its application?
Danish: Vad har företaget lämnat in som stöd för sin ansökan?
English: Around a fifth of the patients were aged 13 and 14 years.
Danish: Ungefär en femtedel av patienterna var i åldern 13 och 14 år.
English: What are the consequences for patients in clinical trials?
Danish: Vilka är följderna för patienter i kliniska prövningar?
English: More information about Abilify is available on EMA's website.
Danish: Mer information om Abilify finns på EMA:s webbplats.
English: If you are in a clinical trial and need more information about your treatment, contact the doctor who is giving it to you.
Danish: Om du deltar i en klinisk prövning och vill få mer information om din behandling kan du kontakta den läkare som ger dig läkemedlet.
English: Its exact mechanism of action is unknown, but it is believed to work through several different receptors in the brain, where it partially mimics or blocks the action of the neurotransmitters dopamine and 5-hydroxytryptamine (also called serotonin).
Danish: Dess exakta verkningsmekanism är okänd, men det anses verka via flera olika receptorer i hjärnan, där det partiellt härmar eller blockerar verkan av neurotransmittorerna dopamin och 5-hydroxytryptamin (även kallat serotonin).
English: The study investigated how effectively Abilify prevented a relapse of their symptoms.
Danish: I studien undersöktes hur effektivt Abilify förhindrade ett återfall av deras symtom.
English: Although the relapse rate with Abilify in 13 and 14 year olds was similar to the rate in older children (21% and 19% respectively), the number of patients in the main study was too small to draw firm conclusions in the younger group.
Danish: Även om återfallsfrekvensen med Abilify hos 13- och 14-åringar var likartad med frekvensen hos äldre barn (21 procent respektive 19 procent), var antalet patienter i huvudstudien för litet för att man skulle kunna dra några definitiva slutsatser i den yngre gruppen.
English: The CHMP did not consider the data supporting the application sufficient to recommend extending the medicine's use.
Danish: CHMP ansåg inte att de data som lämnats in som stöd för ansökan var tillräckliga för att rekommendera en utvidgning av läkemedlets användning.
English: Because these neurotransmitters are involved in schizophrenia and bipolar disorder, aripiprazole can help to normalise their activity in the brain, reducing psychotic or manic symptoms and preventing them from returning.
Danish: Eftersom dessa neurotransmittorer medverkar vid schizofreni och bipolär sjukdom kan aripiprazol bidra till att normalisera deras verkan på hjärnan, vilket minskar de psykotiska eller maniska symtomen och hindrar dem från att återkomma.
English: What is happening with Abilify for the treatment of other diseases?
Danish: Vad händer med Abilify vid behandling av andra sjukdomar?
English: For schizophrenia it is currently approved only for patients aged 15 years and over.
Danish: För schizofreni är det för närvarande godkänt endast för patienter som är 15 år och äldre.